|
|
Volumn 342, Issue 24, 2000, Pages 1824-1826
|
|
Thrombotic thrombocytopenic purpura and clopidogrel - A need for new approaches to drug safety
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOPIDOGREL;
TICLOPIDINE;
DRUG APPROVAL;
DRUG SAFETY;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
POSTMARKETING SURVEILLANCE;
PRIORITY JOURNAL;
THROMBOCYTE AGGREGATION INHIBITION;
THROMBOTIC THROMBOCYTOPENIC PURPURA;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
HUMANS;
PLATELET AGGREGATION INHIBITORS;
PRODUCT SURVEILLANCE, POSTMARKETING;
PURPURA, THROMBOTIC THROMBOCYTOPENIC;
TICLOPIDINE;
UNITED STATES;
|
|
EID: 0034660474
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200006153422410 Document Type: Editorial |
|
Times cited : (58)
|
|
References (10)
|
